Genesco Inc. Files 10-Q for Period Ending August 3, 2024
Ticker: GCO · Form: 10-Q · Filed: Sep 12, 2024 · CIK: 18498
Sentiment: neutral
Topics: 10-Q, financials, retail
TL;DR
Genesco's Q2 2024 10-Q is in. Check financials.
AI Summary
Genesco Inc. reported its second quarter results for the period ending August 3, 2024. The company's fiscal year ends on February 1st. Key financial data and segment performance are detailed within this 10-Q filing.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational details of Genesco Inc., crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: medium — 10-Q filings are standard financial reports, but the specific details within can reveal varying levels of risk related to the company's performance and market conditions.
Key Players & Entities
- GENESCO INC (company) — Filer
- 20240803 (date) — Period of Report
- 20240912 (date) — Filed as of Date
- 0000018498 (company) — Central Index Key
- 535 MARRIOTT DRIVE (address) — Business Address
- NASHVILLE (location) — Business City
- TN (location) — Business State
- 37214 (zip_code) — Business Zip
- 6153677000 (phone_number) — Business Phone
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20240803, indicating the period ending August 3, 2024.
When was this 10-Q filing submitted to the SEC?
The filing was submitted on 20240912.
What is Genesco Inc.'s Central Index Key (CIK)?
Genesco Inc.'s Central Index Key is 0000018498.
What is the fiscal year end for Genesco Inc.?
Genesco Inc.'s fiscal year ends on 0201.
What is the primary business address listed for Genesco Inc.?
The primary business address is 535 MARRIOTT DRIVE, 12TH FLOOR, NASHVILLE, TN 37214.
Filing Stats: 4,580 words · 18 min read · ~15 pages · Grade level 13.7 · Accepted 2024-09-12 10:54:26
Key Financial Figures
- $1.00 — nge on which registered Common Stock, $1.00 par value GCO New York Stock Exchan
Filing Documents
- gco-20240803.htm (10-Q) — 1726KB
- gco-ex31_1.htm (EX-31.1) — 9KB
- gco-ex31_2.htm (EX-31.2) — 9KB
- gco-ex32_1.htm (EX-32.1) — 5KB
- gco-ex32_2.htm (EX-32.2) — 5KB
- 0000950170-24-105736.txt ( ) — 6574KB
- gco-20240803.xsd (EX-101.SCH) — 745KB
- gco-20240803_htm.xml (XML) — 1303KB
Financial Information
Part I. Financial Information
Financial Statements
Item 1. Financial Statements: Condensed Consolidated Balance Sheets - August 3, 2024, February 3, 2024 and July 29, 2023 4 Condensed Consolidated Statements of Operations - Three and Six Months ended August 3, 2024 and July 29, 2023 5 Condensed Consolidated Statements of Comprehensive Loss - Three and Six Months ended August 3, 2024 and July 29, 2023 6 Condensed Consolidated Statements of Cash Flows - Three and Six Months ended August 3, 2024 and July 29, 2023 7 Condensed Consolidated Statements of Equity - Three and Six Months ended August 3, 2024 and July 29, 2023 8 Notes to Condensed Consolidated Financial Statements 9
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 15
Quantitative and Qualitative Disclosures about Market Risk
Item 3. Quantitative and Qualitative Disclosures about Market Risk 23
Controls and Procedures
Item 4. Controls and Procedures 23
Other Information
Part II. Other Information 24
Legal Proceedings
Item 1. Legal Proceedings 24
Risk Factors
Item 1A. Risk Factors 24
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 24
Other Information
Item 5. Other Information 24
Exhibits
Item 6. Exhibits 25 Signature 26 2 cautionary notice regarding forward-looking statements
- FINANC IAL INFORMATION
PART I - FINANC IAL INFORMATION
Financial Sta tements (unaudited)
Item 1. Financial Sta tements (unaudited) Genesco Inc. and Subsidiaries Condensed Consolida ted Balance Sheets (In thousands, except share amounts) Assets August 3, 2024 February 3, 2024 July 29, 2023 Current Assets: Cash $ 45,855 $ 35,155 $ 37,416 Accounts receivable, net of allowances of $ 2,409 at August 3, 2024, $ 4,266 at February 3, 2024 and $ 4,536 at July 29, 2023 57,497 53,618 50,351 Inventories 450,187 378,967 491,118 Prepaids and other current assets 53,181 39,611 45,983 Total current assets 606,720 507,351 624,868 Property and equipment, net 229,116 240,266 244,090 Operating lease right of use assets 402,715 436,896 476,715 Non-current prepaid income taxes 58,051 56,839 55,028 Goodwill 9,284 9,565 9,717 Other intangibles 27,162 27,250 27,952 Deferred income taxes 25,287 26,230 30,623 Other noncurrent assets 25,416 25,493 25,766 Total Assets 1,383,751 1,329,890 1,494,759 Liabilities and Equity Current Liabilities: Accounts payable 187,439 114,621 166,504 Current portion - operating lease liabilities 122,527 129,189 137,369 Other accrued liabilities 85,697 75,727 78,707 Total current liabilities 395,663 319,537 382,580 Long-term debt 77,839 34,682 131,544 Long-term operating lease liabilities 329,773 359,073 403,413 Other long-term liabilities 47,854 45,396 44,203 Total liabilities 851,129 758,688 961,740 Commitments and contingent liabilities — — — Equity Non-redeemable preferred stock 812 813 812 Common equity: Common stock, $ 1 par value: Authorized: 80,000,000 shares Issued common stock 11,707 11,961 11,996 Additional paid-in capital 325,775 319,143 313,019 Retained earnings 251,351 296,766 263,081 Accumulated other comprehensive loss ( 39,166 ) ( 39,624 ) ( 38,032 ) Treasury shares, at cost ( 488